loadpatents
Patent applications and USPTO patent grants for Wan; Lifeng.The latest application filed is for "fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections".
Patent | Date |
---|---|
Tricyclic compounds useful to treat orthomyxovirus infections Grant 11,453,677 - Jain , et al. September 27, 2 | 2022-09-27 |
Fused Tricyclic Pyridazinone Compounds Useful to Treat Orthomyxovirus Infections App 20220041610 - JAIN; Rama ;   et al. | 2022-02-10 |
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections Grant 11,098,051 - Jain , et al. August 24, 2 | 2021-08-24 |
10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione Derivatives And Related Compounds As Inhibitors Of The Orthomyxovirus Replication For Treating Influenza App 20200407366 - DAUPHINAIS; Maxime ;   et al. | 2020-12-31 |
Tricyclic compounds useful to treat orthomyxovirus infections Grant 10,858,366 - Jain , et al. December 8, 2 | 2020-12-08 |
Tricyclic Compounds Useful to Treat Orthomyxovirus Infections App 20200347072 - JAIN; Rama ;   et al. | 2020-11-05 |
Biaryl amide compounds as kinase inhibitors Grant 10,709,712 - Aversa , et al. | 2020-07-14 |
Fused Tricyclic Pyridazinone Compounds Useful To Treat Orthomyxovirus Infections App 20200123167 - JAIN; Rama ;   et al. | 2020-04-23 |
Compounds and compositions as kinase inhibitors Grant 10,392,404 - Barsanti , et al. A | 2019-08-27 |
Biaryl Amide Compounds As Kinase Inhibitors App 20190175606 - AVERSA; Robert John ;   et al. | 2019-06-13 |
Biaryl amide compounds as kinase inhibitors Grant 10,245,267 - Aversa , et al. | 2019-04-02 |
Tricyclic Compounds Useful To Treat Orthomyxovirus Infections App 20190092780 - JAIN; Rama ;   et al. | 2019-03-28 |
Compounds and compositions as RAF kinase inhibitors Grant 10,167,279 - Aversa , et al. J | 2019-01-01 |
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections Grant 10,160,764 - Jain , et al. Dec | 2018-12-25 |
Compounds And Compositions As Raf Kinase Inhibitors App 20180170917 - AVERSA; Robert John ;   et al. | 2018-06-21 |
Fused Tricyclic Pyridazinone Compounds Useful To Treat Orthomyxovirus Infections App 20180057501 - JAIN; Rama ;   et al. | 2018-03-01 |
Biaryl Amide Compounds As Kinase Inhibitors App 20170260207 - AVERSA; Robert John ;   et al. | 2017-09-14 |
Compounds And Compositions As Kinase Inhibitors App 20170260200 - BARSANTI; Paul Andrew ;   et al. | 2017-09-14 |
Biaryl amide compounds as kinase inhibitors Grant 9,694,016 - Aversa , et al. July 4, 2 | 2017-07-04 |
Biaryl Amide Compounds As Kinase Inhibitors App 20160038504 - AVERSA; Robert John ;   et al. | 2016-02-11 |
Heteroaryl Compounds And Their Uses App 20140288076 - Barsanti; Paul A. ;   et al. | 2014-09-25 |
Tetrasubstituted Cyclohexyl Compounds As Kinase Inhibitors App 20140228363 - Burger; Matthew ;   et al. | 2014-08-14 |
Heteroaryl compounds and their uses Grant 8,778,951 - Barsanti , et al. July 15, 2 | 2014-07-15 |
3-(aminoaryl)-pyridine Compounds App 20130324530 - Antonios-McCrea; William R. ;   et al. | 2013-12-05 |
Substituted Hetero-biaryl Compounds And Their Uses App 20130303507 - Antonios-McCrea; William R. ;   et al. | 2013-11-14 |
Heteroaryl Compounds And Their Uses App 20130172354 - Barsanti; Paul A. ;   et al. | 2013-07-04 |
Cyclic Ether Compounds Useful As Kinase Inhibitors App 20130109682 - Burger; Matthew ;   et al. | 2013-05-02 |
Heteroaryl compounds and their uses Grant 8,415,381 - Barsanti , et al. April 9, 2 | 2013-04-09 |
Novel Kinase Inhibitors App 20120225062 - Burger; Matthew ;   et al. | 2012-09-06 |
Tetrasubstituted Cyclohexyl Compounds As Kinase Inhibitors App 20120225061 - Burger; Matthew ;   et al. | 2012-09-06 |
Heteroaryl Compounds and Their Uses App 20110028492 - Barsanti; Paul A. ;   et al. | 2011-02-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.